CMS Releases 2016 Open Payments Data
Conclusion
Visitors to the CMS Open Payments website can look up individual clinicians and hospitals to see what they have received from drug and device makers and compare their payments to national and specialty averages.
Related StoriesOpen Payments Starts Review and Dispute…On A SaturdayChicago Releases Pharmaceutical Representative Disclosure Log DraftCalifornia Gift Ban Bill to be Heard Tomorrow (Source: Policy and Medicine)
Source: Policy and Medicine - July 3, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
CMS Releases 2016 Open Payment Data
Conclusion
Visitors to the CMS Open Payments website can look up individual clinicians and hospitals to see what they have received from drug and device makers and compare their payments to national and specialty averages.
Related StoriesOpen Payments Starts Review and Dispute…On A SaturdayChicago Releases Pharmaceutical Representative Disclosure Log DraftCalifornia Gift Ban Bill to be Heard Tomorrow (Source: Policy and Medicine)
Source: Policy and Medicine - July 3, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
The 21st Century Cures Act: Is It Worth the Cost for Lifesciences?
This article explores whether the long-term the Act’s benefits will outweigh the costs.
The 21st Century Cures Act (“Act”), passed by the U.S. Congress and signed into law by former U.S. President Obama on December 13, 2016, legislatively boosts funding for a host of government research and regulatory programs including $4.8 billion for the National Institutes
of Health (“NIH”); $1.8 billion to accelerate research for cancer; $1.6 billion for brain diseases including Alzheimer’s; $500 million in funding for the U.S. Food and Drug Administration (“FDA”) and $1 billion in grants to assis...
Source: Policy and Medicine - June 30, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
RAND Releases Study on MACRA Implementation
According to a RAND study in Health Affairs, MACRA will slow the rate of growth for the program's spending on physician services, saving anywhere from $35 billion to $106 billion over 15 years. Over this time, the relative drop in revenue under MACRA is still better than what could have transpired under Medicare's former reimbursement system. With plenty of uncertainty surrounding MACRA's implementation, the RAND forecast is useful, but due to potential changes in MACRA, the study’s results may need to be revisited in the future.
Study Findings
Two important findings from the study: First, Medicare spending on physicia...
Source: Policy and Medicine - June 30, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Chicago Releases Pharmaceutical Representative Disclosure Log Draft
The City of Chicago recently released a draft of the disclosure log pharmaceutical representatives will be expected to use to keep track of the interactions they have with Chicago physicians. The form requires pharmaceutical representatives to log the following information with respect to any interactions they have with physicians within city limits: HCP first name; HCP middle initial/name; HCP last name; HCP name suffix (i.e., Jr.); HCP primary business address; HCP license type (i.e., MD, DO, etc.); HCP state license number; HCP NPI (if applicable); date of interaction; location of interaction; duration of interaction; p...
Source: Policy and Medicine - June 29, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
